{"title":"NaV1.8抑制剂有望提供无阿片类药物疼痛缓解","authors":"Katie Kingwell","doi":"10.1038/d41573-024-00203-3","DOIUrl":null,"url":null,"abstract":"Vertex’s first-in-class suzetrigine could soon usher in a new class of analgesic. Vertex’s first-in-class suzetrigine could soon usher in a new class of analgesic.","PeriodicalId":19068,"journal":{"name":"Nature Reviews. Drug Discovery","volume":"24 1","pages":"3-5"},"PeriodicalIF":122.7000,"publicationDate":"2024-12-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"NaV1.8 inhibitor poised to provide opioid-free pain relief\",\"authors\":\"Katie Kingwell\",\"doi\":\"10.1038/d41573-024-00203-3\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Vertex’s first-in-class suzetrigine could soon usher in a new class of analgesic. Vertex’s first-in-class suzetrigine could soon usher in a new class of analgesic.\",\"PeriodicalId\":19068,\"journal\":{\"name\":\"Nature Reviews. Drug Discovery\",\"volume\":\"24 1\",\"pages\":\"3-5\"},\"PeriodicalIF\":122.7000,\"publicationDate\":\"2024-12-12\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature Reviews. Drug Discovery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.nature.com/articles/d41573-024-00203-3\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"BIOTECHNOLOGY & APPLIED MICROBIOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature Reviews. Drug Discovery","FirstCategoryId":"3","ListUrlMain":"https://www.nature.com/articles/d41573-024-00203-3","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"BIOTECHNOLOGY & APPLIED MICROBIOLOGY","Score":null,"Total":0}
NaV1.8 inhibitor poised to provide opioid-free pain relief
Vertex’s first-in-class suzetrigine could soon usher in a new class of analgesic. Vertex’s first-in-class suzetrigine could soon usher in a new class of analgesic.
期刊介绍：
Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena.
Each issue includes:
Highest-quality reviews and perspectives covering a broad scope.
News stories investigating the hottest topics in drug discovery.
Timely summaries of key primary research papers.
Concise updates on the latest advances in areas such as new drug approvals, patent law, and emerging industry trends and strategies.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
